licaminlimab

DRUG2 trials

Sponsors

Oculis

Conditions

Dry Eye DiseaseDry Eye Disease (DED)

Phase 2

Safety and Efficacy of Licaminlimab Ophthalmic Solution for the Treatment of Dry Eye Disease

CompletedNCT05896670

OculisDry Eye Disease

Start: 2023-11-29End: 2024-03-27Updated: 2025-07-02

A Clinical Study Evaluating Licaminlimab for Dry Eye Disease

RecruitingNCT07548632

OculisDry Eye Disease (DED)

Start: 2026-04-16End: 2026-12-01Target: 160Updated: 2026-08-28